# Match Group timeline entity: /record/match-group.md id: ent_match-group ## undated - undated to 1995-12-08 | registrant_name | Match Group, Inc. | superseded | [clm_26E8D12EC487](/claim/clm_26E8D12EC487.md) - undated | ticker | MTCH | valid | [clm_8827D5A54CBB](/claim/clm_8827D5A54CBB.md) - undated | cik | 0000891103 | valid | [clm_9408D0FA1610](/claim/clm_9408D0FA1610.md) - undated | listed_on | Nasdaq | valid | [clm_C09E7AE34526](/claim/clm_C09E7AE34526.md) - undated | state_of_incorporation | DE | valid | [clm_C24E54AD030D](/claim/clm_C24E54AD030D.md) - undated | sic_industry | Services-Computer Programming, Data Processing, Etc. (7370) | valid | [clm_EB47D562588E](/claim/clm_EB47D562588E.md) - undated | fiscal_year_end | 12-31 | valid | [clm_FB5E02BCDB05](/claim/clm_FB5E02BCDB05.md) ## 1995 - 1995-12-08 to 1996-12-24 | registrant_name | SILVER KING COMMUNICATIONS INC | superseded | [clm_D26540FFCD23](/claim/clm_D26540FFCD23.md) ## 1997 - 1997-07-28 to 1998-02-04 | registrant_name | HSN INC | superseded | [clm_D515E39C4289](/claim/clm_D515E39C4289.md) ## 1998 - 1998-09-25 to 2002-05-06 | registrant_name | USA NETWORKS INC | superseded | [clm_0B4D84855791](/claim/clm_0B4D84855791.md) ## 2002 - 2002-05-10 to 2003-05-09 | registrant_name | USA INTERACTIVE | superseded | [clm_46DE38F7D516](/claim/clm_46DE38F7D516.md) ## 2003 - 2003-05-09 to 2004-07-12 | registrant_name | INTERACTIVECORP | superseded | [clm_12AF755CEEC7](/claim/clm_12AF755CEEC7.md) ## 2004 - 2004-07-14 to 2020-07-01 | registrant_name | IAC/INTERACTIVECORP | superseded | [clm_A061686811AD](/claim/clm_A061686811AD.md) ## 2007 - 2007-12-31 to 2008-12-31 | cash_and_equivalents | 1,585,302,000 United States dollar | superseded | [clm_4FD3CDC13794](/claim/clm_4FD3CDC13794.md) ## 2008 - 2008-12-31 to 2009-12-31 | revenue | 1,410,078,000 United States dollar | superseded | [clm_102AD88F9D4B](/claim/clm_102AD88F9D4B.md) - 2008-12-31 to 2009-12-31 | operating_income | -44,254,000 United States dollar | superseded | [clm_4F8A489D3E94](/claim/clm_4F8A489D3E94.md) - 2008-12-31 to 2009-12-31 | research_and_development | 63,817,000 United States dollar | superseded | [clm_6F8CAA3EE6EF](/claim/clm_6F8CAA3EE6EF.md) - 2008-12-31 to 2009-12-31 | net_income | -156,201,000 United States dollar | superseded | [clm_E557FA34D25F](/claim/clm_E557FA34D25F.md) - 2008-12-31 to 2009-06-30 | cash_and_equivalents | 1,744,994,000 United States dollar | superseded | [clm_FEABF2F98D47](/claim/clm_FEABF2F98D47.md) ## undated - undated | legal_form | Delaware corporation | unverified | [clm_1CF59C426E0A](/claim/clm_1CF59C426E0A.md) - undated | member_of | Internet Association | unverified | [clm_554A534AE68F](/claim/clm_554A534AE68F.md) - undated | website | http://mtch.com/ | unverified | [clm_C046E76F74BF](/claim/clm_C046E76F74BF.md) ## 2009 - 2009-06-30 to 2009-09-30 | quarterly_revenue | 340,045,000 United States dollar | superseded | [clm_210828E432D9](/claim/clm_210828E432D9.md) - 2009-06-30 to 2009-09-30 | quarterly_net_income | 40,813,000 United States dollar | superseded | [clm_42BD2CF13F84](/claim/clm_42BD2CF13F84.md) - 2009-06-30 to 2009-09-30 | cash_and_equivalents | 1,608,422,000 United States dollar | superseded | [clm_8A5FCD09D8C0](/claim/clm_8A5FCD09D8C0.md) - 2009-06-30 to 2009-09-30 | quarterly_operating_income | 3,907,000 United States dollar | superseded | [clm_9E57ACAC798E](/claim/clm_9E57ACAC798E.md) - 2009-06-30 to 2009-09-30 | quarterly_research_and_development | 16,422,000 United States dollar | superseded | [clm_B5857F492762](/claim/clm_B5857F492762.md) - 2009-09-30 to 2009-12-31 | cash_and_equivalents | 1,405,770,000 United States dollar | superseded | [clm_1760A7726339](/claim/clm_1760A7726339.md) - 2009-09-30 to 2010-03-31 | quarterly_revenue | 336,577,000 United States dollar | superseded | [clm_580A75426862](/claim/clm_580A75426862.md) - 2009-09-30 to 2010-03-31 | quarterly_research_and_development | 12,972,000 United States dollar | superseded | [clm_898E478AF85E](/claim/clm_898E478AF85E.md) - 2009-09-30 to 2010-03-31 | quarterly_net_income | 21,682,000 United States dollar | superseded | [clm_A5AA738CE21A](/claim/clm_A5AA738CE21A.md) - 2009-09-30 to 2010-03-31 | quarterly_operating_income | 7,121,000 United States dollar | superseded | [clm_C5EC21B0E191](/claim/clm_C5EC21B0E191.md) - 2009-12-31 to 2010-12-31 | revenue | 1,346,695,000 United States dollar | superseded | [clm_10B21E130B77](/claim/clm_10B21E130B77.md) - 2009-12-31 to 2010-12-31 | research_and_development | 57,843,000 United States dollar | superseded | [clm_241C75FB8B66](/claim/clm_241C75FB8B66.md) - 2009-12-31 to 2010-12-31 | operating_income | -1,037,987,000 United States dollar | superseded | [clm_5DEA8AD667FE](/claim/clm_5DEA8AD667FE.md) - 2009-12-31 to 2010-03-31 | cash_and_equivalents | 1,245,997,000 United States dollar | superseded | [clm_8EB22FA188EA](/claim/clm_8EB22FA188EA.md) - 2009-12-31 to 2010-06-30 | total_assets | 4,015,889,000 United States dollar | superseded | [clm_9F17DEE525D5](/claim/clm_9F17DEE525D5.md) - 2009-12-31 to 2010-12-31 | net_income | -978,822,000 United States dollar | superseded | [clm_DC1C39FEE429](/claim/clm_DC1C39FEE429.md) ## 2010 - 2010-03-31 to 2010-06-30 | quarterly_operating_income | 8,925,000 United States dollar | superseded | [clm_3A58CF21F2DD](/claim/clm_3A58CF21F2DD.md) - 2010-03-31 to 2010-06-30 | cash_and_equivalents | 952,272,000 United States dollar | superseded | [clm_3DF026DD0725](/claim/clm_3DF026DD0725.md) - 2010-03-31 to 2010-06-30 | quarterly_revenue | 378,178,000 United States dollar | superseded | [clm_772078677325](/claim/clm_772078677325.md) - 2010-03-31 to 2010-06-30 | quarterly_research_and_development | 14,792,000 United States dollar | superseded | [clm_A1D216A9CA34](/claim/clm_A1D216A9CA34.md) - 2010-03-31 to 2010-06-30 | quarterly_net_income | -18,705,000 United States dollar | superseded | [clm_C4A948712F80](/claim/clm_C4A948712F80.md) - 2010-06-30 to 2010-09-30 | quarterly_operating_income | 23,726,000 United States dollar | superseded | [clm_206B7582B1E6](/claim/clm_206B7582B1E6.md) - 2010-06-30 to 2010-09-30 | quarterly_research_and_development | 15,345,000 United States dollar | superseded | [clm_3085947B3B65](/claim/clm_3085947B3B65.md) - 2010-06-30 to 2010-09-30 | total_assets | 3,714,912,000 United States dollar | superseded | [clm_38ED1009C391](/claim/clm_38ED1009C391.md) - 2010-06-30 to 2010-09-30 | quarterly_net_income | 13,591,000 United States dollar | superseded | [clm_7C72F123B6B3](/claim/clm_7C72F123B6B3.md) - 2010-06-30 to 2010-09-30 | cash_and_equivalents | 915,169,000 United States dollar | superseded | [clm_92886F6EBA5F](/claim/clm_92886F6EBA5F.md) - 2010-06-30 to 2010-09-30 | quarterly_revenue | 402,858,000 United States dollar | superseded | [clm_C8A01F811299](/claim/clm_C8A01F811299.md) - 2010-07-23 to 2010-10-22 | shares_outstanding | 104,594,041 shares | superseded | [clm_155065A75B9A](/claim/clm_155065A75B9A.md) - 2010-09-30 to 2010-12-31 | cash_and_equivalents | 902,214,000 United States dollar | superseded | [clm_053748035A73](/claim/clm_053748035A73.md) - 2010-09-30 to 2011-03-31 | quarterly_revenue | 421,652,000 United States dollar | superseded | [clm_15031C500580](/claim/clm_15031C500580.md) - 2010-09-30 to 2010-12-31 | total_assets | 3,612,198,000 United States dollar | superseded | [clm_496F2528F693](/claim/clm_496F2528F693.md) - 2010-09-30 to 2011-03-31 | quarterly_research_and_development | 17,812,000 United States dollar | superseded | [clm_5F077D83EEB2](/claim/clm_5F077D83EEB2.md) - 2010-09-30 to 2011-03-31 | quarterly_operating_income | 35,934,000 United States dollar | superseded | [clm_8328C3C86F92](/claim/clm_8328C3C86F92.md) - 2010-09-30 to 2011-03-31 | quarterly_net_income | 17,509,000 United States dollar | superseded | [clm_940134AD941F](/claim/clm_940134AD941F.md) - 2010-10-22 to 2011-04-22 | shares_outstanding | 100,382,241 shares | superseded | [clm_72299CA7410E](/claim/clm_72299CA7410E.md) - 2010-12-31 to 2011-12-31 | operating_income | 49,795,000 United States dollar | superseded | [clm_467704CBBAE8](/claim/clm_467704CBBAE8.md) - 2010-12-31 to 2011-03-31 | total_assets | 3,439,554,000 United States dollar | superseded | [clm_7EB489C72C57](/claim/clm_7EB489C72C57.md) - 2010-12-31 to 2011-12-31 | research_and_development | 65,097,000 United States dollar | superseded | [clm_88911DF73A9B](/claim/clm_88911DF73A9B.md) - 2010-12-31 to 2011-12-31 | revenue | 1,636,815,000 United States dollar | superseded | [clm_B43DF5012A2B](/claim/clm_B43DF5012A2B.md) - 2010-12-31 to 2011-09-30 | total_equity | 2,050,068,000 United States dollar | superseded | [clm_C4B4BA4F2624](/claim/clm_C4B4BA4F2624.md) - 2010-12-31 | net_income | 99,359,000 United States dollar | valid | [clm_DA333D4369C4](/claim/clm_DA333D4369C4.md) - 2010-12-31 to 2011-03-31 | cash_and_equivalents | 742,099,000 United States dollar | superseded | [clm_DC500F074138](/claim/clm_DC500F074138.md) ## 2011 - 2011-03-31 to 2011-06-30 | quarterly_operating_income | 37,336,000 United States dollar | superseded | [clm_4BB1B7A44294](/claim/clm_4BB1B7A44294.md) - 2011-03-31 to 2011-06-30 | quarterly_net_income | 18,070,000 United States dollar | superseded | [clm_4DFFFCAD137B](/claim/clm_4DFFFCAD137B.md) - 2011-03-31 to 2011-06-30 | cash_and_equivalents | 848,595,000 United States dollar | superseded | [clm_63C21D9EBC42](/claim/clm_63C21D9EBC42.md) - 2011-03-31 to 2011-06-30 | quarterly_research_and_development | 17,722,000 United States dollar | superseded | [clm_693E91512048](/claim/clm_693E91512048.md) - 2011-03-31 to 2011-06-30 | quarterly_revenue | 460,213,000 United States dollar | superseded | [clm_E94DB20B92ED](/claim/clm_E94DB20B92ED.md) - 2011-03-31 to 2011-06-30 | total_assets | 3,536,629,000 United States dollar | superseded | [clm_F613D38A1415](/claim/clm_F613D38A1415.md) - 2011-04-22 to 2020-07-31 | shares_outstanding | 89,888,134 shares | superseded | [clm_E33D92EE1FA7](/claim/clm_E33D92EE1FA7.md) - 2011-06-30 to 2011-09-30 | quarterly_operating_income | 58,231,000 United States dollar | superseded | [clm_21FA610F4B51](/claim/clm_21FA610F4B51.md) - 2011-06-30 to 2011-09-30 | total_assets | 3,509,301,000 United States dollar | superseded | [clm_26CDA5570296](/claim/clm_26CDA5570296.md) - 2011-06-30 to 2011-09-30 | cash_and_equivalents | 622,866,000 United States dollar | superseded | [clm_2DA807DCAAE9](/claim/clm_2DA807DCAAE9.md) - 2011-06-30 to 2011-09-30 | quarterly_research_and_development | 17,280,000 United States dollar | superseded | [clm_35750197AFB0](/claim/clm_35750197AFB0.md) - 2011-06-30 to 2011-09-30 | quarterly_revenue | 485,404,000 United States dollar | superseded | [clm_67486570C3CB](/claim/clm_67486570C3CB.md) - 2011-06-30 to 2011-09-30 | quarterly_net_income | 42,424,000 United States dollar | superseded | [clm_69A971A0B15B](/claim/clm_69A971A0B15B.md) - 2011-09-30 to 2012-03-31 | quarterly_research_and_development | 21,556,000 United States dollar | superseded | [clm_2490A68C690A](/claim/clm_2490A68C690A.md) - 2011-09-30 to 2013-03-31 | quarterly_net_income | 64,973,000 United States dollar | superseded | [clm_2BC39C55AFB6](/claim/clm_2BC39C55AFB6.md) - 2011-09-30 to 2012-03-31 | quarterly_operating_income | 46,740,000 United States dollar | superseded | [clm_3A4B6DDAA04B](/claim/clm_3A4B6DDAA04B.md) - 2011-09-30 to 2011-12-31 | total_equity | 2,306,498,000 United States dollar | superseded | [clm_670AB3825C8A](/claim/clm_670AB3825C8A.md) - 2011-09-30 to 2011-12-31 | cash_and_equivalents | 679,311,000 United States dollar | superseded | [clm_7354E9F8CE35](/claim/clm_7354E9F8CE35.md) - 2011-09-30 to 2011-12-31 | total_assets | 3,548,327,000 United States dollar | superseded | [clm_88A865BC85FC](/claim/clm_88A865BC85FC.md) - 2011-09-30 to 2012-03-31 | quarterly_revenue | 516,884,000 United States dollar | superseded | [clm_8E86C3ED5451](/claim/clm_8E86C3ED5451.md) - 2011-12-31 to 2012-03-31 | total_assets | 3,409,865,000 United States dollar | superseded | [clm_18E80C42DCFC](/claim/clm_18E80C42DCFC.md) - 2011-12-31 to 2012-12-31 | research_and_development | 78,760,000 United States dollar | superseded | [clm_1D0BE63BC9A8](/claim/clm_1D0BE63BC9A8.md) - 2011-12-31 to 2012-03-31 | cash_and_equivalents | 704,153,000 United States dollar | superseded | [clm_5EE676C42032](/claim/clm_5EE676C42032.md) - 2011-12-31 to 2012-12-31 | operating_income | 197,762,000 United States dollar | superseded | [clm_676C82AFC166](/claim/clm_676C82AFC166.md) - 2011-12-31 to 2012-12-31 | revenue | 2,059,444,000 United States dollar | superseded | [clm_72F68A6EC1FF](/claim/clm_72F68A6EC1FF.md) - 2011-12-31 to 2012-03-31 | total_equity | 1,905,049,000 United States dollar | superseded | [clm_EB6A5F689CCE](/claim/clm_EB6A5F689CCE.md) ## 2012 - 2012-03-31 to 2012-06-30 | quarterly_revenue | 640,600,000 United States dollar | superseded | [clm_28283C9A7E70](/claim/clm_28283C9A7E70.md) - 2012-03-31 to 2012-06-30 | quarterly_operating_income | 62,765,000 United States dollar | superseded | [clm_4F0730F643F3](/claim/clm_4F0730F643F3.md) - 2012-03-31 to 2012-06-30 | cash_and_equivalents | 624,096,000 United States dollar | superseded | [clm_984CF3E97D9F](/claim/clm_984CF3E97D9F.md) - 2012-03-31 to 2012-06-30 | total_equity | 1,855,868,000 United States dollar | superseded | [clm_D0D687D78CCD](/claim/clm_D0D687D78CCD.md) - 2012-03-31 to 2012-06-30 | total_assets | 3,352,478,000 United States dollar | superseded | [clm_EC32423C8410](/claim/clm_EC32423C8410.md) - 2012-03-31 to 2012-06-30 | quarterly_research_and_development | 23,482,000 United States dollar | superseded | [clm_FF7F483AE04E](/claim/clm_FF7F483AE04E.md) - 2012-06-30 to 2012-09-30 | quarterly_research_and_development | 23,115,000 United States dollar | superseded | [clm_85F2896F46B6](/claim/clm_85F2896F46B6.md) - 2012-06-30 to 2012-09-30 | cash_and_equivalents | 807,196,000 United States dollar | superseded | [clm_A911E72133D6](/claim/clm_A911E72133D6.md) - 2012-06-30 to 2012-09-30 | total_equity | 1,942,916,000 United States dollar | superseded | [clm_B258211EB4A5](/claim/clm_B258211EB4A5.md) - 2012-06-30 to 2012-09-30 | quarterly_revenue | 680,612,000 United States dollar | superseded | [clm_C1F5795BDB76](/claim/clm_C1F5795BDB76.md) - 2012-06-30 to 2012-09-30 | quarterly_operating_income | 97,476,000 United States dollar | superseded | [clm_C5D21232443E](/claim/clm_C5D21232443E.md) - 2012-06-30 to 2012-09-30 | total_assets | 3,546,348,000 United States dollar | superseded | [clm_FE9573957CEF](/claim/clm_FE9573957CEF.md) - 2012-09-30 to 2013-03-31 | quarterly_operating_income | 78,033,000 United States dollar | superseded | [clm_311E2C33EC5F](/claim/clm_311E2C33EC5F.md) - 2012-09-30 to 2012-12-31 | total_equity | 1,948,394,000 United States dollar | superseded | [clm_610D0F40A7EA](/claim/clm_610D0F40A7EA.md) - 2012-09-30 to 2013-03-31 | quarterly_research_and_development | 24,504,000 United States dollar | superseded | [clm_83271DBA60E4](/claim/clm_83271DBA60E4.md) - 2012-09-30 to 2012-12-31 | cash_and_equivalents | 501,779,000 United States dollar | superseded | [clm_91BBE17315D7](/claim/clm_91BBE17315D7.md) - 2012-09-30 to 2013-03-31 | quarterly_revenue | 714,470,000 United States dollar | superseded | [clm_BC3A4D824077](/claim/clm_BC3A4D824077.md) - 2012-09-30 to 2012-12-31 | total_assets | 3,582,575,000 United States dollar | superseded | [clm_CE76BE8E09EC](/claim/clm_CE76BE8E09EC.md) - 2012-12-31 to 2013-03-31 | cash_and_equivalents | 749,977,000 United States dollar | superseded | [clm_27CF2AD25AD8](/claim/clm_27CF2AD25AD8.md) - 2012-12-31 to 2013-12-31 | operating_income | 323,568,000 United States dollar | superseded | [clm_51B673D93157](/claim/clm_51B673D93157.md) - 2012-12-31 to 2013-03-31 | total_assets | 3,805,828,000 United States dollar | superseded | [clm_98B3ED1EDDDC](/claim/clm_98B3ED1EDDDC.md) - 2012-12-31 to 2013-12-31 | research_and_development | 101,869,000 United States dollar | superseded | [clm_AFE8C6763657](/claim/clm_AFE8C6763657.md) - 2012-12-31 to 2013-12-31 | revenue | 2,800,933,000 United States dollar | superseded | [clm_B4696365BA34](/claim/clm_B4696365BA34.md) - 2012-12-31 to 2013-03-31 | total_equity | 1,655,728,000 United States dollar | superseded | [clm_F5A54B757C9D](/claim/clm_F5A54B757C9D.md) ## 2013 - 2013-03-31 to 2013-06-30 | total_assets | 3,780,246,000 United States dollar | superseded | [clm_2E702700AB9B](/claim/clm_2E702700AB9B.md) - 2013-03-31 to 2013-06-30 | quarterly_revenue | 742,249,000 United States dollar | superseded | [clm_474CCBCB6DB5](/claim/clm_474CCBCB6DB5.md) - 2013-03-31 to 2013-06-30 | quarterly_research_and_development | 33,582,000 United States dollar | superseded | [clm_4D557478ED94](/claim/clm_4D557478ED94.md) - 2013-03-31 to 2013-06-30 | total_equity | 1,636,519,000 United States dollar | superseded | [clm_5053F519CD15](/claim/clm_5053F519CD15.md) - 2013-03-31 to 2013-06-30 | cash_and_equivalents | 673,757,000 United States dollar | superseded | [clm_5516EAC38BBE](/claim/clm_5516EAC38BBE.md) - 2013-03-31 to 2013-06-30 | quarterly_net_income | 53,637,000 United States dollar | superseded | [clm_81BDBA2E30A0](/claim/clm_81BDBA2E30A0.md) - 2013-03-31 to 2013-06-30 | quarterly_operating_income | 84,551,000 United States dollar | superseded | [clm_AE6B7777C464](/claim/clm_AE6B7777C464.md) - 2013-06-30 to 2013-09-30 | cash_and_equivalents | 678,725,000 United States dollar | superseded | [clm_0693C831A452](/claim/clm_0693C831A452.md) - 2013-06-30 to 2013-09-30 | quarterly_net_income | 58,290,000 United States dollar | superseded | [clm_1C0574F1F684](/claim/clm_1C0574F1F684.md) - 2013-06-30 to 2013-09-30 | total_assets | 3,812,491,000 United States dollar | superseded | [clm_29706A633C38](/claim/clm_29706A633C38.md) - 2013-06-30 to 2013-09-30 | quarterly_revenue | 799,411,000 United States dollar | superseded | [clm_2AC7419BE363](/claim/clm_2AC7419BE363.md) - 2013-06-30 to 2013-09-30 | total_equity | 1,631,305,000 United States dollar | superseded | [clm_6F324204D357](/claim/clm_6F324204D357.md) - 2013-06-30 to 2013-09-30 | quarterly_operating_income | 106,696,000 United States dollar | superseded | [clm_99E26DBF696A](/claim/clm_99E26DBF696A.md) - 2013-06-30 to 2013-09-30 | quarterly_research_and_development | 34,052,000 United States dollar | superseded | [clm_B0255589C343](/claim/clm_B0255589C343.md) - 2013-09-30 to 2013-12-31 | cash_and_equivalents | 741,652,000 United States dollar | superseded | [clm_4BC9B8C6F657](/claim/clm_4BC9B8C6F657.md) - 2013-09-30 to 2014-03-31 | quarterly_revenue | 756,872,000 United States dollar | superseded | [clm_4CBD607E8369](/claim/clm_4CBD607E8369.md) - 2013-09-30 to 2014-03-31 | quarterly_net_income | 96,940,000 United States dollar | superseded | [clm_4D4E0C42B35E](/claim/clm_4D4E0C42B35E.md) - 2013-09-30 to 2013-12-31 | total_assets | 3,804,782,000 United States dollar | superseded | [clm_6BA8820AE511](/claim/clm_6BA8820AE511.md) - 2013-09-30 to 2014-03-31 | quarterly_operating_income | 122,004,000 United States dollar | superseded | [clm_7453B798C75A](/claim/clm_7453B798C75A.md) - 2013-09-30 to 2014-03-31 | quarterly_research_and_development | 35,232,000 United States dollar | superseded | [clm_92008D66B7CB](/claim/clm_92008D66B7CB.md) - 2013-09-30 to 2013-12-31 | total_equity | 1,735,056,000 United States dollar | superseded | [clm_BFD8A98072D9](/claim/clm_BFD8A98072D9.md) - 2013-12-31 to 2014-03-31 | cash_and_equivalents | 1,100,444,000 United States dollar | superseded | [clm_0743CCBEC6BC](/claim/clm_0743CCBEC6BC.md) - 2013-12-31 to 2014-12-31 | operating_income | 426,203,000 United States dollar | superseded | [clm_15CB28DD5A81](/claim/clm_15CB28DD5A81.md) - 2013-12-31 to 2014-03-31 | total_assets | 4,234,684,000 United States dollar | superseded | [clm_5601C23B52BD](/claim/clm_5601C23B52BD.md) - 2013-12-31 to 2014-12-31 | research_and_development | 141,330,000 United States dollar | superseded | [clm_B573F6C0DDC0](/claim/clm_B573F6C0DDC0.md) - 2013-12-31 to 2014-12-31 | revenue | 3,022,987,000 United States dollar | superseded | [clm_C4935615E8D1](/claim/clm_C4935615E8D1.md) - 2013-12-31 to 2014-03-31 | total_equity | 1,686,736,000 United States dollar | superseded | [clm_FB35783CB237](/claim/clm_FB35783CB237.md) ## 2014 - 2014-03-31 to 2014-06-30 | quarterly_research_and_development | 39,016,000 United States dollar | superseded | [clm_3005823B376C](/claim/clm_3005823B376C.md) - 2014-03-31 to 2014-06-30 | total_equity | 1,709,494,000 United States dollar | superseded | [clm_69905A841203](/claim/clm_69905A841203.md) - 2014-03-31 to 2014-06-30 | quarterly_operating_income | 71,712,000 United States dollar | superseded | [clm_7A3E9F83CC95](/claim/clm_7A3E9F83CC95.md) - 2014-03-31 to 2014-06-30 | quarterly_net_income | 35,885,000 United States dollar | superseded | [clm_938F249BED86](/claim/clm_938F249BED86.md) - 2014-03-31 to 2014-06-30 | total_assets | 4,224,056,000 United States dollar | superseded | [clm_98C2CBFA0DE7](/claim/clm_98C2CBFA0DE7.md) - 2014-03-31 to 2014-06-30 | cash_and_equivalents | 1,003,311,000 United States dollar | superseded | [clm_D53C884B199D](/claim/clm_D53C884B199D.md) - 2014-03-31 to 2014-06-30 | quarterly_revenue | 740,247,000 United States dollar | superseded | [clm_DCE0056335F0](/claim/clm_DCE0056335F0.md) - 2014-06-30 to 2014-09-30 | total_assets | 4,167,478,000 United States dollar | superseded | [clm_079201E16B2F](/claim/clm_079201E16B2F.md) - 2014-06-30 to 2014-09-30 | cash_and_equivalents | 987,326,000 United States dollar | superseded | [clm_91DBE579BF2D](/claim/clm_91DBE579BF2D.md) - 2014-06-30 to 2014-09-30 | quarterly_operating_income | 95,690,000 United States dollar | superseded | [clm_9B9916EA03E7](/claim/clm_9B9916EA03E7.md) - 2014-06-30 to 2014-09-30 | quarterly_revenue | 756,315,000 United States dollar | superseded | [clm_A028B807F18D](/claim/clm_A028B807F18D.md) - 2014-06-30 to 2014-09-30 | quarterly_net_income | -17,996,000 United States dollar | superseded | [clm_C896BDE5AC89](/claim/clm_C896BDE5AC89.md) - 2014-06-30 to 2014-09-30 | quarterly_research_and_development | 38,357,000 United States dollar | superseded | [clm_DB6FF3357031](/claim/clm_DB6FF3357031.md) - 2014-06-30 to 2014-09-30 | total_equity | 1,672,928,000 United States dollar | superseded | [clm_EE482578093C](/claim/clm_EE482578093C.md) - 2014-09-30 to 2014-12-31 | total_assets | 4,238,410,000 United States dollar | superseded | [clm_178E72FDFB9A](/claim/clm_178E72FDFB9A.md) - 2014-09-30 to 2015-03-31 | quarterly_revenue | 782,231,000 United States dollar | superseded | [clm_2E1EB0D74E30](/claim/clm_2E1EB0D74E30.md) - 2014-09-30 to 2015-03-31 | quarterly_net_income | 326,812,000 United States dollar | superseded | [clm_730DBF8FFE29](/claim/clm_730DBF8FFE29.md) - 2014-09-30 to 2014-12-31 | total_equity | 1,975,028,000 United States dollar | superseded | [clm_A767D5A245FB](/claim/clm_A767D5A245FB.md) - 2014-09-30 to 2014-12-31 | cash_and_equivalents | 931,712,000 United States dollar | superseded | [clm_B164D92FA05E](/claim/clm_B164D92FA05E.md) - 2014-09-30 to 2015-03-31 | quarterly_operating_income | 100,953,000 United States dollar | superseded | [clm_DB237717A2BA](/claim/clm_DB237717A2BA.md) - 2014-09-30 to 2015-03-31 | quarterly_research_and_development | 39,686,000 United States dollar | superseded | [clm_F2D4258FA88F](/claim/clm_F2D4258FA88F.md) - 2014-12-31 to 2015-12-31 | operating_income | 378,727,000 United States dollar | superseded | [clm_1C51B0C51815](/claim/clm_1C51B0C51815.md) - 2014-12-31 to 2015-12-31 | research_and_development | 160,515,000 United States dollar | superseded | [clm_5D1476803361](/claim/clm_5D1476803361.md) - 2014-12-31 to 2015-12-31 | revenue | 3,109,547,000 United States dollar | superseded | [clm_6AEB8E36242C](/claim/clm_6AEB8E36242C.md) - 2014-12-31 to 2015-03-31 | total_assets | 4,274,878,000 United States dollar | superseded | [clm_6AFE4918C6C5](/claim/clm_6AFE4918C6C5.md) - 2014-12-31 to 2015-03-31 | cash_and_equivalents | 990,405,000 United States dollar | superseded | [clm_7040D9B596E0](/claim/clm_7040D9B596E0.md) - 2014-12-31 to 2015-03-31 | total_equity | 1,991,953,000 United States dollar | superseded | [clm_7889BB361147](/claim/clm_7889BB361147.md) ## 2015 - 2015-03-31 to 2015-06-30 | total_equity | 1,752,714,000 United States dollar | superseded | [clm_05C98F567B01](/claim/clm_05C98F567B01.md) - 2015-03-31 to 2015-06-30 | quarterly_revenue | 772,512,000 United States dollar | superseded | [clm_33EFA87461AE](/claim/clm_33EFA87461AE.md) - 2015-03-31 to 2015-06-30 | quarterly_operating_income | 35,119,000 United States dollar | superseded | [clm_78D10FCDABA6](/claim/clm_78D10FCDABA6.md) - 2015-03-31 to 2015-06-30 | quarterly_research_and_development | 45,257,000 United States dollar | superseded | [clm_A777E9168E52](/claim/clm_A777E9168E52.md) - 2015-03-31 to 2015-06-30 | total_assets | 3,958,105,000 United States dollar | superseded | [clm_CEA597093B37](/claim/clm_CEA597093B37.md) - 2015-03-31 to 2015-06-30 | quarterly_net_income | 26,405,000 United States dollar | superseded | [clm_D76BAB146245](/claim/clm_D76BAB146245.md) - 2015-03-31 to 2015-06-30 | cash_and_equivalents | 671,597,000 United States dollar | superseded | [clm_E7DF8F5FE180](/claim/clm_E7DF8F5FE180.md) - 2015-06-30 to 2015-09-30 | quarterly_operating_income | 62,769,000 United States dollar | superseded | [clm_381D1C2171C1](/claim/clm_381D1C2171C1.md) - 2015-06-30 to 2015-09-30 | total_equity | 1,815,386,000 United States dollar | superseded | [clm_3F97408854EA](/claim/clm_3F97408854EA.md) - 2015-06-30 to 2015-09-30 | total_assets | 4,075,058,000 United States dollar | superseded | [clm_4EEA4CCB1CCE](/claim/clm_4EEA4CCB1CCE.md) - 2015-06-30 to 2015-09-30 | cash_and_equivalents | 656,409,000 United States dollar | superseded | [clm_6617460AE604](/claim/clm_6617460AE604.md) - 2015-06-30 to 2015-09-30 | quarterly_revenue | 771,132,000 United States dollar | superseded | [clm_7CE6A9EBFE04](/claim/clm_7CE6A9EBFE04.md) - 2015-06-30 to 2015-09-30 | quarterly_net_income | 59,305,000 United States dollar | superseded | [clm_D1DDC2D77F54](/claim/clm_D1DDC2D77F54.md) - 2015-06-30 to 2015-09-30 | quarterly_research_and_development | 46,430,000 United States dollar | superseded | [clm_EDD689B71342](/claim/clm_EDD689B71342.md) - 2015-09-30 to 2016-03-31 | quarterly_operating_income | 87,130,000 United States dollar | superseded | [clm_39623E5A29A8](/claim/clm_39623E5A29A8.md) - 2015-09-30 to 2015-12-31 | total_equity | 1,845,191,000 United States dollar | superseded | [clm_562E6DA5C5CF](/claim/clm_562E6DA5C5CF.md) - 2015-09-30 to 2015-12-31 | total_assets | 4,027,318,000 United States dollar | superseded | [clm_74A7221A1D6D](/claim/clm_74A7221A1D6D.md) - 2015-09-30 to 2016-03-31 | quarterly_net_income | 65,611,000 United States dollar | superseded | [clm_7A3882E54DC2](/claim/clm_7A3882E54DC2.md) - 2015-09-30 to 2016-03-31 | quarterly_research_and_development | 46,859,000 United States dollar | superseded | [clm_8185E28DA183](/claim/clm_8185E28DA183.md) - 2015-09-30 to 2015-12-31 | cash_and_equivalents | 766,448,000 United States dollar | superseded | [clm_DA08289A43CE](/claim/clm_DA08289A43CE.md) - 2015-09-30 to 2016-03-31 | quarterly_revenue | 838,561,000 United States dollar | superseded | [clm_EF26B0BB2204](/claim/clm_EF26B0BB2204.md) - 2015-12-31 to 2016-03-31 | total_assets | 5,209,950,000 United States dollar | superseded | [clm_575B4DEEF58B](/claim/clm_575B4DEEF58B.md) - 2015-12-31 to 2016-03-31 | total_equity | 1,804,526,000 United States dollar | superseded | [clm_5D619FE137F1](/claim/clm_5D619FE137F1.md) - 2015-12-31 to 2016-12-31 | research_and_development | 185,766,000 United States dollar | superseded | [clm_7F34519AEA4C](/claim/clm_7F34519AEA4C.md) - 2015-12-31 to 2016-12-31 | operating_income | 179,588,000 United States dollar | superseded | [clm_8F69D75C7FE8](/claim/clm_8F69D75C7FE8.md) - 2015-12-31 to 2016-12-31 | revenue | 3,230,933,000 United States dollar | superseded | [clm_CF8FDDACCC86](/claim/clm_CF8FDDACCC86.md) - 2015-12-31 to 2016-03-31 | cash_and_equivalents | 1,481,447,000 United States dollar | superseded | [clm_F506CBFBCAA4](/claim/clm_F506CBFBCAA4.md) ## 2016 - 2016-03-31 to 2016-06-30 | total_assets | 5,052,343,000 United States dollar | superseded | [clm_0DDEA5C02B12](/claim/clm_0DDEA5C02B12.md) - 2016-03-31 to 2016-06-30 | quarterly_revenue | 819,179,000 United States dollar | superseded | [clm_1FC30CBA1B52](/claim/clm_1FC30CBA1B52.md) - 2016-03-31 to 2016-06-30 | cash_and_equivalents | 1,238,664,000 United States dollar | superseded | [clm_225A8173E663](/claim/clm_225A8173E663.md) - 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 55,830,000 United States dollar | superseded | [clm_62111CEAAAE1](/claim/clm_62111CEAAAE1.md) - 2016-03-31 to 2016-06-30 | quarterly_operating_income | 21,417,000 United States dollar | superseded | [clm_9B0D882A1D09](/claim/clm_9B0D882A1D09.md) - 2016-03-31 to 2016-06-30 | quarterly_net_income | 8,282,000 United States dollar | superseded | [clm_9EA999FC35CD](/claim/clm_9EA999FC35CD.md) - 2016-03-31 to 2016-06-30 | total_equity | 2,065,438,000 United States dollar | superseded | [clm_EFAE7D9C3104](/claim/clm_EFAE7D9C3104.md) - 2016-06-30 to 2016-09-30 | total_assets | 4,660,022,000 United States dollar | superseded | [clm_55390BE60915](/claim/clm_55390BE60915.md) - 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 49,911,000 United States dollar | superseded | [clm_5C423883BF56](/claim/clm_5C423883BF56.md) - 2016-06-30 to 2016-09-30 | cash_and_equivalents | 1,245,984,000 United States dollar | superseded | [clm_5CC3F0ABD7BE](/claim/clm_5CC3F0ABD7BE.md) - 2016-06-30 to 2016-09-30 | quarterly_revenue | 745,439,000 United States dollar | superseded | [clm_5F9A61872331](/claim/clm_5F9A61872331.md) - 2016-06-30 to 2016-09-30 | quarterly_net_income | -194,775,000 United States dollar | superseded | [clm_A7B96F9545A7](/claim/clm_A7B96F9545A7.md) - 2016-06-30 to 2016-09-30 | total_equity | 1,814,450,000 United States dollar | superseded | [clm_DE53C79CAFFC](/claim/clm_DE53C79CAFFC.md) - 2016-06-30 to 2016-09-30 | quarterly_operating_income | -252,446,000 United States dollar | superseded | [clm_ED65B4B1B4F6](/claim/clm_ED65B4B1B4F6.md) - 2016-09-30 to 2017-03-31 | quarterly_operating_income | 85,584,000 United States dollar | superseded | [clm_1DF702B9D8CB](/claim/clm_1DF702B9D8CB.md) - 2016-09-30 to 2016-12-31 | cash_and_equivalents | 1,189,784,000 United States dollar | superseded | [clm_4F59E5E06051](/claim/clm_4F59E5E06051.md) - 2016-09-30 to 2017-03-31 | quarterly_revenue | 764,102,000 United States dollar | superseded | [clm_63971615E021](/claim/clm_63971615E021.md) - 2016-09-30 to 2017-03-31 | quarterly_net_income | 43,162,000 United States dollar | superseded | [clm_99FD6E5E5F2F](/claim/clm_99FD6E5E5F2F.md) - 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 45,947,000 United States dollar | superseded | [clm_C1E4FDEDC0FF](/claim/clm_C1E4FDEDC0FF.md) - 2016-09-30 to 2016-12-31 | total_assets | 4,671,160,000 United States dollar | superseded | [clm_D49814542CDD](/claim/clm_D49814542CDD.md) - 2016-09-30 to 2016-12-31 | total_equity | 1,863,866,000 United States dollar | superseded | [clm_DB78211A64E0](/claim/clm_DB78211A64E0.md) - 2016-12-31 to 2017-12-31 | revenue | 3,139,882,000 United States dollar | superseded | [clm_1434F49A75C9](/claim/clm_1434F49A75C9.md) - 2016-12-31 to 2017-03-31 | total_assets | 4,645,873,000 United States dollar | superseded | [clm_292E8A5D5B05](/claim/clm_292E8A5D5B05.md) - 2016-12-31 to 2017-12-31 | operating_income | -32,625,000 United States dollar | superseded | [clm_CF875A42F690](/claim/clm_CF875A42F690.md) - 2016-12-31 to 2017-03-31 | cash_and_equivalents | 1,329,187,000 United States dollar | superseded | [clm_DF635878F7A5](/claim/clm_DF635878F7A5.md) - 2016-12-31 to 2017-03-31 | total_equity | 1,869,222,000 United States dollar | superseded | [clm_F4F3A54FBBD2](/claim/clm_F4F3A54FBBD2.md) - 2016-12-31 to 2017-12-31 | research_and_development | 197,885,000 United States dollar | superseded | [clm_FE7E70FC5D79](/claim/clm_FE7E70FC5D79.md) ## 2017 - 2017-03-31 to 2017-06-30 | quarterly_net_income | 26,209,000 United States dollar | superseded | [clm_0783AC9E37B9](/claim/clm_0783AC9E37B9.md) - 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 54,760,000 United States dollar | superseded | [clm_552F1735DE96](/claim/clm_552F1735DE96.md) - 2017-03-31 to 2017-06-30 | quarterly_revenue | 760,833,000 United States dollar | superseded | [clm_9275250F7E2B](/claim/clm_9275250F7E2B.md) - 2017-03-31 to 2017-06-30 | cash_and_equivalents | 1,397,038,000 United States dollar | superseded | [clm_9BC17E013E85](/claim/clm_9BC17E013E85.md) - 2017-03-31 to 2017-06-30 | total_equity | 1,848,059,000 United States dollar | superseded | [clm_DB96C2820C78](/claim/clm_DB96C2820C78.md) - 2017-03-31 to 2017-06-30 | quarterly_operating_income | 37,060,000 United States dollar | superseded | [clm_DD03AB420C16](/claim/clm_DD03AB420C16.md) - 2017-03-31 to 2017-06-30 | total_assets | 4,619,327,000 United States dollar | superseded | [clm_EB197E024E07](/claim/clm_EB197E024E07.md) - 2017-06-30 to 2017-09-30 | quarterly_operating_income | 75,635,000 United States dollar | superseded | [clm_0DEF7338ACA2](/claim/clm_0DEF7338ACA2.md) - 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 55,430,000 United States dollar | superseded | [clm_0F8A8CD56107](/claim/clm_0F8A8CD56107.md) - 2017-06-30 to 2017-09-30 | quarterly_net_income | 66,268,000 United States dollar | superseded | [clm_620160BAF318](/claim/clm_620160BAF318.md) - 2017-06-30 to 2017-09-30 | total_assets | 4,786,067,000 United States dollar | superseded | [clm_7B1398AB7CAA](/claim/clm_7B1398AB7CAA.md) - 2017-06-30 to 2017-09-30 | total_equity | 1,965,177,000 United States dollar | superseded | [clm_851A56218641](/claim/clm_851A56218641.md) - 2017-06-30 to 2017-09-30 | quarterly_revenue | 767,387,000 United States dollar | superseded | [clm_8D32D64669F6](/claim/clm_8D32D64669F6.md) - 2017-06-30 to 2017-09-30 | cash_and_equivalents | 1,522,300,000 United States dollar | superseded | [clm_C8F1513AD78D](/claim/clm_C8F1513AD78D.md) - 2017-09-30 to 2018-03-31 | quarterly_revenue | 828,434,000 United States dollar | superseded | [clm_2229932E4254](/claim/clm_2229932E4254.md) - 2017-09-30 to 2017-12-31 | total_equity | 2,428,921,000 United States dollar | superseded | [clm_60EE691C43BD](/claim/clm_60EE691C43BD.md) - 2017-09-30 to 2017-12-31 | total_assets | 5,540,955,000 United States dollar | superseded | [clm_6DB5603269B7](/claim/clm_6DB5603269B7.md) - 2017-09-30 to 2018-03-31 | quarterly_net_income | 179,643,000 United States dollar | superseded | [clm_B277B2AB16A4](/claim/clm_B277B2AB16A4.md) - 2017-09-30 to 2018-03-31 | quarterly_operating_income | -18,589,000 United States dollar | superseded | [clm_E08E60AC2E03](/claim/clm_E08E60AC2E03.md) - 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 70,645,000 United States dollar | superseded | [clm_E58240C3929F](/claim/clm_E58240C3929F.md) - 2017-09-30 to 2017-12-31 | cash_and_equivalents | 1,255,317,000 United States dollar | superseded | [clm_E66FD1A27C4A](/claim/clm_E66FD1A27C4A.md) - 2017-12-31 to 2018-03-31 | total_equity | 2,430,028,000 United States dollar | superseded | [clm_19073D2A2024](/claim/clm_19073D2A2024.md) - 2017-12-31 to 2018-12-31 | research_and_development | 250,879,000 United States dollar | superseded | [clm_2336C93313D5](/claim/clm_2336C93313D5.md) - 2017-12-31 to 2018-12-31 | revenue | 3,307,239,000 United States dollar | superseded | [clm_3734CA1AB3AA](/claim/clm_3734CA1AB3AA.md) - 2017-12-31 to 2018-12-31 | operating_income | 188,466,000 United States dollar | superseded | [clm_D6200AEABDA4](/claim/clm_D6200AEABDA4.md) - 2017-12-31 to 2018-03-31 | cash_and_equivalents | 1,630,809,000 United States dollar | superseded | [clm_DD9860F4A00A](/claim/clm_DD9860F4A00A.md) - 2017-12-31 to 2018-03-31 | total_assets | 5,867,810,000 United States dollar | superseded | [clm_E1AE5B6B4BAD](/claim/clm_E1AE5B6B4BAD.md) ## 2018 - 2018-03-31 to 2018-06-30 | total_assets | 6,030,974,000 United States dollar | superseded | [clm_1B91A0567FAB](/claim/clm_1B91A0567FAB.md) - 2018-03-31 to 2018-06-30 | quarterly_revenue | 995,075,000 United States dollar | superseded | [clm_2788C2779BF8](/claim/clm_2788C2779BF8.md) - 2018-03-31 to 2018-06-30 | quarterly_net_income | 71,082,000 United States dollar | superseded | [clm_412191171149](/claim/clm_412191171149.md) - 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 76,937,000 United States dollar | superseded | [clm_4D5405F110DA](/claim/clm_4D5405F110DA.md) - 2018-03-31 to 2018-06-30 | cash_and_equivalents | 1,657,537,000 United States dollar | superseded | [clm_8DAAC818EA15](/claim/clm_8DAAC818EA15.md) - 2018-03-31 to 2018-06-30 | quarterly_operating_income | 89,950,000 United States dollar | superseded | [clm_9892EDB87AD6](/claim/clm_9892EDB87AD6.md) - 2018-03-31 to 2018-06-30 | total_equity | 2,494,527,000 United States dollar | superseded | [clm_E01CCCB6D799](/claim/clm_E01CCCB6D799.md) - 2018-06-30 to 2018-09-30 | quarterly_revenue | 1,059,122,000 United States dollar | superseded | [clm_3869CBEEF81F](/claim/clm_3869CBEEF81F.md) - 2018-06-30 to 2018-09-30 | total_equity | 2,576,079,000 United States dollar | superseded | [clm_46A78969A5B0](/claim/clm_46A78969A5B0.md) - 2018-06-30 to 2018-09-30 | quarterly_net_income | 218,353,000 United States dollar | superseded | [clm_5F684B2EA4A1](/claim/clm_5F684B2EA4A1.md) - 2018-06-30 to 2018-09-30 | total_assets | 6,235,284,000 United States dollar | superseded | [clm_939233FAE00B](/claim/clm_939233FAE00B.md) - 2018-06-30 to 2018-09-30 | quarterly_operating_income | 168,437,000 United States dollar | superseded | [clm_AFB646EC32F7](/claim/clm_AFB646EC32F7.md) - 2018-06-30 to 2018-09-30 | cash_and_equivalents | 1,644,829,000 United States dollar | superseded | [clm_DEED108CCD80](/claim/clm_DEED108CCD80.md) - 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 75,445,000 United States dollar | superseded | [clm_E2FA7566D03D](/claim/clm_E2FA7566D03D.md) - 2018-09-30 to 2019-03-31 | quarterly_operating_income | 172,832,000 United States dollar | superseded | [clm_1CDEF4CC453D](/claim/clm_1CDEF4CC453D.md) - 2018-09-30 to 2018-12-31 | total_assets | 6,372,347,000 United States dollar | superseded | [clm_300FF67386BD](/claim/clm_300FF67386BD.md) - 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 77,740,000 United States dollar | superseded | [clm_75D4A6A23CD6](/claim/clm_75D4A6A23CD6.md) - 2018-09-30 to 2019-03-31 | quarterly_net_income | 145,774,000 United States dollar | superseded | [clm_8087EB4E7A40](/claim/clm_8087EB4E7A40.md) - 2018-09-30 to 2019-03-31 | quarterly_revenue | 1,104,592,000 United States dollar | superseded | [clm_D740F2DA9ED1](/claim/clm_D740F2DA9ED1.md) - 2018-09-30 to 2018-12-31 | cash_and_equivalents | 1,670,984,000 United States dollar | superseded | [clm_E81F62CE3363](/claim/clm_E81F62CE3363.md) - 2018-09-30 to 2018-12-31 | total_equity | 2,600,482,000 United States dollar | superseded | [clm_FB7660D3354C](/claim/clm_FB7660D3354C.md) - 2018-12-31 to 2019-03-31 | total_assets | 6,874,585,000 United States dollar | superseded | [clm_0844B0997FE1](/claim/clm_0844B0997FE1.md) - 2018-12-31 to 2019-03-31 | total_equity | 2,843,125,000 United States dollar | superseded | [clm_1A90078B78E0](/claim/clm_1A90078B78E0.md) - 2018-12-31 to 2019-03-31 | cash_and_equivalents | 2,131,632,000 United States dollar | superseded | [clm_5B9E8AB53909](/claim/clm_5B9E8AB53909.md) - 2018-12-31 to 2019-12-31 | revenue | 4,262,892,000 United States dollar | superseded | [clm_932305C4CCDB](/claim/clm_932305C4CCDB.md) - 2018-12-31 to 2019-12-31 | research_and_development | 309,329,000 United States dollar | superseded | [clm_C3E0F9F00D0D](/claim/clm_C3E0F9F00D0D.md) - 2018-12-31 to 2019-12-31 | operating_income | 565,139,000 United States dollar | superseded | [clm_ECEC07CF3435](/claim/clm_ECEC07CF3435.md) ## 2019 - 2019-03-31 to 2019-06-30 | total_equity | 2,779,861,000 United States dollar | superseded | [clm_126304DBB9BF](/claim/clm_126304DBB9BF.md) - 2019-03-31 to 2019-06-30 | cash_and_equivalents | 2,217,337,000 United States dollar | superseded | [clm_2CF16417FCEF](/claim/clm_2CF16417FCEF.md) - 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 88,700,000 United States dollar | superseded | [clm_3FB0A6013E92](/claim/clm_3FB0A6013E92.md) - 2019-03-31 to 2019-06-30 | quarterly_operating_income | 79,873,000 United States dollar | superseded | [clm_5E0106E1C46C](/claim/clm_5E0106E1C46C.md) - 2019-03-31 to 2019-06-30 | total_assets | 7,159,902,000 United States dollar | superseded | [clm_90751C8E8815](/claim/clm_90751C8E8815.md) - 2019-03-31 to 2019-06-30 | quarterly_revenue | 1,105,843,000 United States dollar | superseded | [clm_B2EAEC812818](/claim/clm_B2EAEC812818.md) - 2019-03-31 to 2019-06-30 | quarterly_net_income | 88,695,000 United States dollar | superseded | [clm_E7EFBAD27BD1](/claim/clm_E7EFBAD27BD1.md) - 2019-06-30 to 2019-09-30 | total_equity | 2,983,461,000 United States dollar | superseded | [clm_28263B4B4F1E](/claim/clm_28263B4B4F1E.md) - 2019-06-30 to 2019-09-30 | cash_and_equivalents | 3,151,959,000 United States dollar | superseded | [clm_2F89C5DCC46A](/claim/clm_2F89C5DCC46A.md) - 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 78,614,000 United States dollar | superseded | [clm_396E4054159E](/claim/clm_396E4054159E.md) - 2019-06-30 to 2019-09-30 | total_assets | 8,299,105,000 United States dollar | superseded | [clm_7CE83B038846](/claim/clm_7CE83B038846.md) - 2019-06-30 to 2019-09-30 | quarterly_revenue | 497,973,000 United States dollar | superseded | [clm_90770CB6F96C](/claim/clm_90770CB6F96C.md) - 2019-06-30 to 2019-09-30 | quarterly_operating_income | 154,310,000 United States dollar | superseded | [clm_F3E02541F836](/claim/clm_F3E02541F836.md) - 2019-06-30 to 2019-09-30 | quarterly_net_income | 113,467,000 United States dollar | superseded | [clm_FFD871EA42C1](/claim/clm_FFD871EA42C1.md) - 2019-09-30 to 2020-03-31 | quarterly_net_income | 128,544,000 United States dollar | superseded | [clm_130A25C2946D](/claim/clm_130A25C2946D.md) - 2019-09-30 to 2020-03-31 | quarterly_revenue | 541,493,000 United States dollar | superseded | [clm_27583BEC8FB9](/claim/clm_27583BEC8FB9.md) - 2019-09-30 to 2019-12-31 | total_assets | 8,304,791,000 United States dollar | superseded | [clm_30449E130D4A](/claim/clm_30449E130D4A.md) - 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 86,600,000 United States dollar | superseded | [clm_885294524F70](/claim/clm_885294524F70.md) - 2019-09-30 to 2019-12-31 | total_equity | 2,897,274,000 United States dollar | superseded | [clm_8E2C8789865B](/claim/clm_8E2C8789865B.md) - 2019-09-30 to 2020-03-31 | quarterly_operating_income | 185,852,000 United States dollar | superseded | [clm_E1D63D4071FA](/claim/clm_E1D63D4071FA.md) - 2019-09-30 to 2019-12-31 | cash_and_equivalents | 2,946,180,000 United States dollar | superseded | [clm_F55253812865](/claim/clm_F55253812865.md) - 2019-12-31 to 2020-03-31 | cash_and_equivalents | 3,139,295,000 United States dollar | superseded | [clm_1268BDC0CA53](/claim/clm_1268BDC0CA53.md) - 2019-12-31 to 2020-03-31 | total_assets | 8,332,825,000 United States dollar | superseded | [clm_38B03E0E0E18](/claim/clm_38B03E0E0E18.md) - 2019-12-31 to 2020-12-31 | revenue | 4,757,055,000 United States dollar | superseded | [clm_88CA497BD2E8](/claim/clm_88CA497BD2E8.md) - 2019-12-31 to 2020-12-31 | research_and_development | 345,417,000 United States dollar | superseded | [clm_DFBEC7214926](/claim/clm_DFBEC7214926.md) - 2019-12-31 to 2020-03-31 | total_equity | 2,928,042,000 United States dollar | superseded | [clm_F03F8E43D30F](/claim/clm_F03F8E43D30F.md) - 2019-12-31 to 2020-12-31 | operating_income | 581,333,000 United States dollar | superseded | [clm_FCBAA2068DC1](/claim/clm_FCBAA2068DC1.md) ## 2020 - 2020-03-31 to 2020-06-30 | cash_and_equivalents | 2,822,729,000 United States dollar | superseded | [clm_24F6844EFE62](/claim/clm_24F6844EFE62.md) - 2020-03-31 to 2020-06-30 | quarterly_operating_income | -177,780,000 United States dollar | superseded | [clm_851EBD71FD64](/claim/clm_851EBD71FD64.md) - 2020-03-31 to 2020-06-30 | total_equity | 2,424,410,000 United States dollar | superseded | [clm_89F2501A0966](/claim/clm_89F2501A0966.md) - 2020-03-31 to 2020-06-30 | total_assets | 8,434,749,000 United States dollar | superseded | [clm_A0595F253138](/claim/clm_A0595F253138.md) - 2020-03-31 to 2020-06-30 | quarterly_revenue | 544,642,000 United States dollar | superseded | [clm_AE4FEB6FE164](/claim/clm_AE4FEB6FE164.md) - 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 105,733,000 United States dollar | superseded | [clm_E2561016694A](/claim/clm_E2561016694A.md) - 2020-03-31 to 2025-03-31 | quarterly_net_income | -211,040,000 United States dollar | superseded | [clm_E9988BBDA883](/claim/clm_E9988BBDA883.md) - 2020-06-30 to 2020-09-30 | quarterly_operating_income | 195,594,000 United States dollar | superseded | [clm_5C8AE80116F4](/claim/clm_5C8AE80116F4.md) - 2020-06-30 to 2020-09-30 | cash_and_equivalents | 129,294,000 United States dollar | superseded | [clm_66E2143DCB83](/claim/clm_66E2143DCB83.md) - 2020-06-30 to 2020-09-30 | total_assets | 2,334,732,000 United States dollar | superseded | [clm_70C0BAFA231C](/claim/clm_70C0BAFA231C.md) - 2020-06-30 to 2020-09-30 | total_equity | -1,708,175,000 United States dollar | superseded | [clm_A693BB0FB713](/claim/clm_A693BB0FB713.md) - 2020-06-30 to 2020-09-30 | quarterly_revenue | 555,450,000 United States dollar | superseded | [clm_CDAD7BDC0EF6](/claim/clm_CDAD7BDC0EF6.md) - 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 41,929,000 United States dollar | superseded | [clm_D270553079D5](/claim/clm_D270553079D5.md) - 2020-07-31 to 2020-10-30 | shares_outstanding | 260,016,024 shares | superseded | [clm_71B5119D5A05](/claim/clm_71B5119D5A05.md) - 2020-09-30 to 2021-03-31 | quarterly_operating_income | 200,167,000 United States dollar | superseded | [clm_0592CF229558](/claim/clm_0592CF229558.md) - 2020-09-30 to 2020-12-31 | total_assets | 2,670,092,000 United States dollar | superseded | [clm_0A74342F907F](/claim/clm_0A74342F907F.md) - 2020-09-30 to 2020-12-31 | total_equity | -1,442,934,000 United States dollar | superseded | [clm_6E762DC0570D](/claim/clm_6E762DC0570D.md) - 2020-09-30 to 2020-12-31 | cash_and_equivalents | 398,884,000 United States dollar | superseded | [clm_7D1E6E179EA3](/claim/clm_7D1E6E179EA3.md) - 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 39,280,000 United States dollar | superseded | [clm_A5A8CA4734EE](/claim/clm_A5A8CA4734EE.md) - 2020-09-30 to 2021-03-31 | quarterly_revenue | 639,770,000 United States dollar | superseded | [clm_BCC4DD7A4639](/claim/clm_BCC4DD7A4639.md) - 2020-10-30 to 2021-02-22 | shares_outstanding | 265,983,244 shares | superseded | [clm_9470017B502C](/claim/clm_9470017B502C.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 739,164,000 United States dollar | superseded | [clm_09ED29FEF401](/claim/clm_09ED29FEF401.md) - 2020-12-31 to 2021-12-31 | research_and_development | 169,811,000 United States dollar | superseded | [clm_2B1CD67F893F](/claim/clm_2B1CD67F893F.md) - 2020-12-31 to 2021-03-31 | total_equity | -1,177,667,000 United States dollar | superseded | [clm_2C880EF65FD6](/claim/clm_2C880EF65FD6.md) - 2020-12-31 to 2021-12-31 | revenue | 2,391,269,000 United States dollar | superseded | [clm_32EE50BFD99F](/claim/clm_32EE50BFD99F.md) - 2020-12-31 to 2021-12-31 | operating_income | 745,715,000 United States dollar | superseded | [clm_5C3F97E56629](/claim/clm_5C3F97E56629.md) - 2020-12-31 to 2021-03-31 | total_assets | 2,976,980,000 United States dollar | superseded | [clm_768881057281](/claim/clm_768881057281.md) ## 2021 - 2021-02-22 to 2021-05-01 | shares_outstanding | 268,971,789 shares | superseded | [clm_5E8C5C4B8E58](/claim/clm_5E8C5C4B8E58.md) - 2021-03-31 to 2021-06-30 | total_equity | -1,214,591,000 United States dollar | superseded | [clm_0F60810FD09E](/claim/clm_0F60810FD09E.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | 189,258,000 United States dollar | superseded | [clm_3E738E5DC0AF](/claim/clm_3E738E5DC0AF.md) - 2021-03-31 to 2021-06-30 | quarterly_revenue | 667,612,000 United States dollar | superseded | [clm_984BBE40A7CB](/claim/clm_984BBE40A7CB.md) - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 845,696,000 United States dollar | superseded | [clm_A73DC69B1038](/claim/clm_A73DC69B1038.md) - 2021-03-31 to 2021-06-30 | total_assets | 3,214,668,000 United States dollar | superseded | [clm_C9DA9A61875D](/claim/clm_C9DA9A61875D.md) - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 55,576,000 United States dollar | superseded | [clm_FBE886B6F415](/claim/clm_FBE886B6F415.md) - 2021-05-01 to 2021-07-30 | shares_outstanding | 270,274,610 shares | superseded | [clm_5595B4A52C0D](/claim/clm_5595B4A52C0D.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 707,760,000 United States dollar | superseded | [clm_2C88A6B5FDDB](/claim/clm_2C88A6B5FDDB.md) - 2021-06-30 to 2021-09-30 | total_equity | -142,245,000 United States dollar | superseded | [clm_36AB3FD099FD](/claim/clm_36AB3FD099FD.md) - 2021-06-30 to 2021-09-30 | total_assets | 4,433,933,000 United States dollar | superseded | [clm_555125F0185B](/claim/clm_555125F0185B.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | 209,914,000 United States dollar | superseded | [clm_73811FD201E7](/claim/clm_73811FD201E7.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 236,460,000 United States dollar | superseded | [clm_8830B2923EEF](/claim/clm_8830B2923EEF.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 52,133,000 United States dollar | superseded | [clm_8D87960B8BF3](/claim/clm_8D87960B8BF3.md) - 2021-07-30 to 2021-10-29 | shares_outstanding | 276,810,727 shares | superseded | [clm_AA53381272C3](/claim/clm_AA53381272C3.md) - 2021-09-30 to 2021-12-31 | total_equity | -68,352,000 United States dollar | superseded | [clm_4C586D428295](/claim/clm_4C586D428295.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | 220,590,000 United States dollar | superseded | [clm_5BEC7FC41E67](/claim/clm_5BEC7FC41E67.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 801,835,000 United States dollar | superseded | [clm_B3A907676964](/claim/clm_B3A907676964.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 66,974,000 United States dollar | superseded | [clm_C705F90D8A6D](/claim/clm_C705F90D8A6D.md) - 2021-09-30 to 2021-12-31 | total_assets | 4,893,626,000 United States dollar | superseded | [clm_D990F9688EC4](/claim/clm_D990F9688EC4.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 511,311,000 United States dollar | superseded | [clm_FE47157FA759](/claim/clm_FE47157FA759.md) - 2021-10-29 to 2022-02-18 | shares_outstanding | 283,085,312 shares | superseded | [clm_DB8DD88F04A5](/claim/clm_DB8DD88F04A5.md) - 2021-12-31 to 2022-12-31 | revenue | 2,983,277,000 United States dollar | superseded | [clm_258F750904B6](/claim/clm_258F750904B6.md) - 2021-12-31 to 2022-03-31 | total_assets | 5,063,288,000 United States dollar | superseded | [clm_30B28D6E6A0B](/claim/clm_30B28D6E6A0B.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 815,384,000 United States dollar | superseded | [clm_6A6E053A65A9](/claim/clm_6A6E053A65A9.md) - 2021-12-31 to 2022-12-31 | research_and_development | 241,049,000 United States dollar | superseded | [clm_8026A2181480](/claim/clm_8026A2181480.md) - 2021-12-31 to 2022-12-31 | operating_income | 851,679,000 United States dollar | superseded | [clm_862D05E4EA97](/claim/clm_862D05E4EA97.md) - 2021-12-31 to 2022-03-31 | total_equity | -203,769,000 United States dollar | superseded | [clm_A00661FC92F1](/claim/clm_A00661FC92F1.md) ## 2022 - 2022-02-18 to 2022-04-29 | shares_outstanding | 285,148,288 shares | superseded | [clm_2BB87E13726B](/claim/clm_2BB87E13726B.md) - 2022-03-31 to 2022-06-30 | total_equity | -122,449,000 United States dollar | superseded | [clm_06C00F702600](/claim/clm_06C00F702600.md) - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 912,434,000 United States dollar | superseded | [clm_667C48A0999C](/claim/clm_667C48A0999C.md) - 2022-03-31 to 2022-06-30 | total_assets | 5,043,393,000 United States dollar | superseded | [clm_76CED82AB4B5](/claim/clm_76CED82AB4B5.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | 207,818,000 United States dollar | superseded | [clm_7ED3A1D6731E](/claim/clm_7ED3A1D6731E.md) - 2022-03-31 to 2022-06-30 | quarterly_revenue | 798,631,000 United States dollar | superseded | [clm_B8FE103E0297](/claim/clm_B8FE103E0297.md) - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 78,794,000 United States dollar | superseded | [clm_BBEB6BFCAB05](/claim/clm_BBEB6BFCAB05.md) - 2022-04-29 to 2022-07-29 | shares_outstanding | 285,592,764 shares | superseded | [clm_0F647EA1FE56](/claim/clm_0F647EA1FE56.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | -10,081,000 United States dollar | superseded | [clm_3BD81D60285F](/claim/clm_3BD81D60285F.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 86,410,000 United States dollar | superseded | [clm_4701BA03ACCD](/claim/clm_4701BA03ACCD.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 794,513,000 United States dollar | superseded | [clm_4BF5C4C99FA2](/claim/clm_4BF5C4C99FA2.md) - 2022-06-30 to 2022-09-30 | total_equity | -452,945,000 United States dollar | superseded | [clm_65D06772BBE7](/claim/clm_65D06772BBE7.md) - 2022-06-30 to 2022-09-30 | total_assets | 4,193,778,000 United States dollar | superseded | [clm_7CA6AC441FDE](/claim/clm_7CA6AC441FDE.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 463,686,000 United States dollar | superseded | [clm_B1BCB34DF343](/claim/clm_B1BCB34DF343.md) - 2022-07-29 to 2022-10-28 | shares_outstanding | 282,986,452 shares | superseded | [clm_2F58B29D345E](/claim/clm_2F58B29D345E.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | 210,635,000 United States dollar | superseded | [clm_257CE8996EBE](/claim/clm_257CE8996EBE.md) - 2022-09-30 to 2022-12-31 | total_assets | 3,914,549,000 United States dollar | superseded | [clm_27E5CFF364BC](/claim/clm_27E5CFF364BC.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 87,880,000 United States dollar | superseded | [clm_4564297C3336](/claim/clm_4564297C3336.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 390,641,000 United States dollar | superseded | [clm_7020786EDB47](/claim/clm_7020786EDB47.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 809,546,000 United States dollar | superseded | [clm_7F833762C211](/claim/clm_7F833762C211.md) - 2022-09-30 to 2022-12-31 | total_equity | -699,342,000 United States dollar | superseded | [clm_DCF57DDAB63E](/claim/clm_DCF57DDAB63E.md) - 2022-10-28 to 2023-02-17 | shares_outstanding | 279,306,106 shares | superseded | [clm_07195CD9E967](/claim/clm_07195CD9E967.md) - 2022-12-31 to 2023-12-31 | revenue | 3,188,843,000 United States dollar | superseded | [clm_1923CEA77252](/claim/clm_1923CEA77252.md) - 2022-12-31 to 2023-12-31 | research_and_development | 333,639,000 United States dollar | superseded | [clm_1A2828049490](/claim/clm_1A2828049490.md) - 2022-12-31 to 2023-03-31 | total_assets | 4,182,764,000 United States dollar | superseded | [clm_5CAD3C18EE85](/claim/clm_5CAD3C18EE85.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 572,395,000 United States dollar | superseded | [clm_5CCCBF4A8B0B](/claim/clm_5CCCBF4A8B0B.md) - 2022-12-31 to 2023-12-31 | operating_income | 515,005,000 United States dollar | superseded | [clm_A1E46F717235](/claim/clm_A1E46F717235.md) - 2022-12-31 to 2023-03-31 | total_equity | -359,875,000 United States dollar | superseded | [clm_DE94326C7415](/claim/clm_DE94326C7415.md) ## 2023 - 2023-01-26 | president | Gary Swidler | valid | [clm_A6A0C20B6BA3](/claim/clm_A6A0C20B6BA3.md) - 2023-02-17 to 2023-04-28 | shares_outstanding | 279,323,890 shares | superseded | [clm_54EB5DF207B1](/claim/clm_54EB5DF207B1.md) - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 98,186,000 United States dollar | superseded | [clm_245BD74F0F07](/claim/clm_245BD74F0F07.md) - 2023-03-31 to 2023-06-30 | quarterly_operating_income | 198,289,000 United States dollar | superseded | [clm_36219FEC2B27](/claim/clm_36219FEC2B27.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 787,124,000 United States dollar | superseded | [clm_50A526754028](/claim/clm_50A526754028.md) - 2023-03-31 to 2023-06-30 | total_assets | 4,203,909,000 United States dollar | superseded | [clm_C33B8616B0EF](/claim/clm_C33B8616B0EF.md) - 2023-03-31 to 2023-06-30 | total_equity | -334,518,000 United States dollar | superseded | [clm_CDAC207D61F0](/claim/clm_CDAC207D61F0.md) - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 569,879,000 United States dollar | superseded | [clm_EA1CC3B2E36D](/claim/clm_EA1CC3B2E36D.md) - 2023-04-24 | owned_by | The Vanguard Group | unverified | [clm_1920BB408989](/claim/clm_1920BB408989.md) - 2023-04-24 | owned_by | BlackRock | unverified | [clm_8211BAAF5817](/claim/clm_8211BAAF5817.md) - 2023-04-24 | owned_by | Edgewood Management | unverified | [clm_C3DDCCF91092](/claim/clm_C3DDCCF91092.md) - 2023-04-28 to 2023-07-28 | shares_outstanding | 278,460,751 shares | superseded | [clm_257F10B64CD0](/claim/clm_257F10B64CD0.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 829,552,000 United States dollar | superseded | [clm_0ABDDD4B1FF3](/claim/clm_0ABDDD4B1FF3.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 94,287,000 United States dollar | superseded | [clm_4DF0AEC5940A](/claim/clm_4DF0AEC5940A.md) - 2023-06-30 to 2023-09-30 | total_equity | -177,927,000 United States dollar | superseded | [clm_4E3F63CB1577](/claim/clm_4E3F63CB1577.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 732,567,000 United States dollar | superseded | [clm_A28B9BD51971](/claim/clm_A28B9BD51971.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | 214,796,000 United States dollar | superseded | [clm_BD86CDA26D76](/claim/clm_BD86CDA26D76.md) - 2023-06-30 to 2023-09-30 | total_assets | 4,339,027,000 United States dollar | superseded | [clm_F069207C6C08](/claim/clm_F069207C6C08.md) - 2023-07-28 to 2023-10-27 | shares_outstanding | 278,086,755 shares | superseded | [clm_BAAAABAF5599](/claim/clm_BAAAABAF5599.md) - 2023-09-30 to 2023-12-31 | total_assets | 4,248,895,000 United States dollar | superseded | [clm_0F0C6D587507](/claim/clm_0F0C6D587507.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 94,141,000 United States dollar | superseded | [clm_673AC2C9D222](/claim/clm_673AC2C9D222.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 881,600,000 United States dollar | superseded | [clm_6B964A7D312A](/claim/clm_6B964A7D312A.md) - 2023-09-30 to 2023-12-31 | total_equity | -299,438,000 United States dollar | superseded | [clm_788F87231ADA](/claim/clm_788F87231ADA.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 706,881,000 United States dollar | superseded | [clm_A4F8A55B6F06](/claim/clm_A4F8A55B6F06.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | 243,559,000 United States dollar | superseded | [clm_C8B8C4427E3D](/claim/clm_C8B8C4427E3D.md) - 2023-10-27 to 2024-02-21 | shares_outstanding | 271,811,565 shares | superseded | [clm_CBD54BA6256B](/claim/clm_CBD54BA6256B.md) - 2023-12-31 to 2024-03-31 | total_equity | -19,548,000 United States dollar | superseded | [clm_0929DDCEA377](/claim/clm_0929DDCEA377.md) - 2023-12-31 to 2024-12-31 | research_and_development | 384,185,000 United States dollar | superseded | [clm_1660847196CC](/claim/clm_1660847196CC.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 862,440,000 United States dollar | superseded | [clm_5C246A5B5DAF](/claim/clm_5C246A5B5DAF.md) - 2023-12-31 to 2024-12-31 | revenue | 3,364,504,000 United States dollar | superseded | [clm_BFC4672D7A0F](/claim/clm_BFC4672D7A0F.md) - 2023-12-31 to 2024-03-31 | total_assets | 4,507,886,000 United States dollar | superseded | [clm_CCCD7E1CB597](/claim/clm_CCCD7E1CB597.md) - 2023-12-31 to 2024-12-31 | operating_income | 916,896,000 United States dollar | superseded | [clm_ECD477CB8DCC](/claim/clm_ECD477CB8DCC.md) ## 2024 - 2024-02-21 to 2024-05-03 | shares_outstanding | 268,011,754 shares | superseded | [clm_6FE79B19D937](/claim/clm_6FE79B19D937.md) - 2024-03-24 | board_member | Spencer Rascoff | valid | [clm_1A8CAF6F7E71](/claim/clm_1A8CAF6F7E71.md) - 2024-03-24 | board_member | Laura Jones | valid | [clm_22535D62B557](/claim/clm_22535D62B557.md) - 2024-03-31 to 2024-06-30 | quarterly_operating_income | 184,738,000 United States dollar | superseded | [clm_342356EE91B6](/claim/clm_342356EE91B6.md) - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 914,929,000 United States dollar | superseded | [clm_4368D532984C](/claim/clm_4368D532984C.md) - 2024-03-31 to 2024-06-30 | total_equity | -107,810,000 United States dollar | superseded | [clm_49412F94538B](/claim/clm_49412F94538B.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 115,737,000 United States dollar | superseded | [clm_6DCAB96DB81F](/claim/clm_6DCAB96DB81F.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 859,647,000 United States dollar | superseded | [clm_8A626153A07A](/claim/clm_8A626153A07A.md) - 2024-03-31 to 2024-06-30 | total_assets | 4,403,453,000 United States dollar | superseded | [clm_B9F2510DE0A2](/claim/clm_B9F2510DE0A2.md) - 2024-05-03 to 2024-07-26 | shares_outstanding | 265,668,115 shares | superseded | [clm_70C1769C2FC0](/claim/clm_70C1769C2FC0.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 864,066,000 United States dollar | superseded | [clm_24F66B58984B](/claim/clm_24F66B58984B.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 837,792,000 United States dollar | superseded | [clm_3E63E255EC6F](/claim/clm_3E63E255EC6F.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | 204,526,000 United States dollar | superseded | [clm_493E56BB0986](/claim/clm_493E56BB0986.md) - 2024-06-30 to 2024-09-30 | total_equity | -130,240,000 United States dollar | superseded | [clm_98BAD43EEDB8](/claim/clm_98BAD43EEDB8.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 113,576,000 United States dollar | superseded | [clm_D246513896C4](/claim/clm_D246513896C4.md) - 2024-06-30 to 2024-09-30 | total_assets | 4,368,929,000 United States dollar | superseded | [clm_E07328E89DDD](/claim/clm_E07328E89DDD.md) - 2024-07-26 to 2024-11-01 | shares_outstanding | 257,895,012 shares | superseded | [clm_3496BDC4E3E8](/claim/clm_3496BDC4E3E8.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 855,532,000 United States dollar | superseded | [clm_16042775BB3E](/claim/clm_16042775BB3E.md) - 2024-09-30 to 2024-12-31 | total_assets | 4,425,837,000 United States dollar | superseded | [clm_22FC786A9C1C](/claim/clm_22FC786A9C1C.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 895,484,000 United States dollar | superseded | [clm_5909A5F38EAA](/claim/clm_5909A5F38EAA.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 103,724,000 United States dollar | superseded | [clm_B4E9BE39C11B](/claim/clm_B4E9BE39C11B.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | 210,660,000 United States dollar | superseded | [clm_C047E8A3B08C](/claim/clm_C047E8A3B08C.md) - 2024-09-30 to 2024-12-31 | total_equity | -88,526,000 United States dollar | superseded | [clm_FB20EE12DFCB](/claim/clm_FB20EE12DFCB.md) - 2024-11-01 to 2025-02-21 | shares_outstanding | 251,090,997 shares | superseded | [clm_182238AE632C](/claim/clm_182238AE632C.md) - 2024-12-31 to 2025-03-31 | total_equity | -63,659,000 United States dollar | superseded | [clm_5DD802359C01](/claim/clm_5DD802359C01.md) - 2024-12-31 to 2025-12-31 | operating_income | 823,312,000 United States dollar | superseded | [clm_6CCEEE4DDBD0](/claim/clm_6CCEEE4DDBD0.md) - 2024-12-31 to 2025-12-31 | revenue | 3,479,373,000 United States dollar | superseded | [clm_78E5C1AE2382](/claim/clm_78E5C1AE2382.md) - 2024-12-31 to 2025-12-31 | research_and_development | 442,175,000 United States dollar | superseded | [clm_A91D81575BF6](/claim/clm_A91D81575BF6.md) - 2024-12-31 to 2025-03-31 | total_assets | 4,465,771,000 United States dollar | superseded | [clm_A9BDBB270880](/claim/clm_A9BDBB270880.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 965,993,000 United States dollar | superseded | [clm_F48EA1D4DB4F](/claim/clm_F48EA1D4DB4F.md) ## 2025 - 2025-02-04 | ceo | Spencer Rascoff | valid | [clm_71D469A8D2FA](/claim/clm_71D469A8D2FA.md) - 2025-02-21 to 2025-04-30 | shares_outstanding | 250,429,132 shares | superseded | [clm_AF11AD1BB80F](/claim/clm_AF11AD1BB80F.md) - 2025-03-01 | cfo | Steven Bailey | valid | [clm_ABCEE3781F6D](/claim/clm_ABCEE3781F6D.md) - 2025-03-31 to 2025-06-30 | total_assets | 3,889,885,000 United States dollar | superseded | [clm_2632180820A4](/claim/clm_2632180820A4.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | 172,593,000 United States dollar | superseded | [clm_375CB38B1C67](/claim/clm_375CB38B1C67.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 120,854,000 United States dollar | superseded | [clm_3DD957917EC0](/claim/clm_3DD957917EC0.md) - 2025-03-31 to 2025-06-30 | total_equity | -182,712,000 United States dollar | superseded | [clm_47D4B24F7531](/claim/clm_47D4B24F7531.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 831,178,000 United States dollar | superseded | [clm_5409355A85D1](/claim/clm_5409355A85D1.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | 117,570,000 United States dollar | superseded | [clm_D0F6E86DC630](/claim/clm_D0F6E86DC630.md) - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 409,422,000 United States dollar | superseded | [clm_E71ECA8B656D](/claim/clm_E71ECA8B656D.md) - 2025-04-01 | coo | Hesam Hosseini | valid | [clm_B590EDDF8A74](/claim/clm_B590EDDF8A74.md) - 2025-04-30 to 2025-07-31 | shares_outstanding | 245,225,322 shares | superseded | [clm_A1F7F52F06AF](/claim/clm_A1F7F52F06AF.md) - 2025-06-18 | board_member | Darrell Cavens | valid | [clm_474A351946F7](/claim/clm_474A351946F7.md) - 2025-06-30 to 2026-03-31 | quarterly_net_income | 125,478,000 United States dollar | superseded | [clm_1C15ECAEC279](/claim/clm_1C15ECAEC279.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 335,243,000 United States dollar | superseded | [clm_3BA0495EE9E8](/claim/clm_3BA0495EE9E8.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | 193,921,000 United States dollar | superseded | [clm_45105F4073F7](/claim/clm_45105F4073F7.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 114,511,000 United States dollar | superseded | [clm_6125846245C4](/claim/clm_6125846245C4.md) - 2025-06-30 to 2025-09-30 | total_equity | -230,881,000 United States dollar | superseded | [clm_9D3169E62000](/claim/clm_9D3169E62000.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 863,738,000 United States dollar | superseded | [clm_ABEA9586ABDC](/claim/clm_ABEA9586ABDC.md) - 2025-06-30 to 2025-09-30 | total_assets | 3,867,816,000 United States dollar | superseded | [clm_C558D5706DE4](/claim/clm_C558D5706DE4.md) - 2025-07-31 to 2025-10-31 | shares_outstanding | 240,622,147 shares | superseded | [clm_6AB9E7FCB40B](/claim/clm_6AB9E7FCB40B.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 1,053,240,000 United States dollar | superseded | [clm_144779448117](/claim/clm_144779448117.md) - 2025-09-30 to 2025-12-31 | total_assets | 4,543,439,000 United States dollar | superseded | [clm_1E343841B171](/claim/clm_1E343841B171.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 104,969,000 United States dollar | superseded | [clm_1F124837D5EB](/claim/clm_1F124837D5EB.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | 221,334,000 United States dollar | superseded | [clm_62B71B58D29A](/claim/clm_62B71B58D29A.md) - 2025-09-30 to 2025-12-31 | total_equity | -223,936,000 United States dollar | superseded | [clm_724B00C314FC](/claim/clm_724B00C314FC.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 914,275,000 United States dollar | superseded | [clm_FBC459F93C22](/claim/clm_FBC459F93C22.md) - 2025-10-31 to 2026-02-20 | shares_outstanding | 236,070,189 shares | superseded | [clm_C42F17E7D270](/claim/clm_C42F17E7D270.md) - 2025-12-31 | research_and_development | 449,508,000 United States dollar | valid | [clm_03905E34A4AB](/claim/clm_03905E34A4AB.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 1,027,838,000 United States dollar | superseded | [clm_1B8B0A925906](/claim/clm_1B8B0A925906.md) - 2025-12-31 to 2026-03-31 | total_assets | 4,460,811,000 United States dollar | superseded | [clm_53C15A896338](/claim/clm_53C15A896338.md) - 2025-12-31 | revenue | 3,487,197,000 United States dollar | valid | [clm_620D5484D930](/claim/clm_620D5484D930.md) - 2025-12-31 | operating_income | 872,529,000 United States dollar | valid | [clm_656A4E7CE997](/claim/clm_656A4E7CE997.md) - 2025-12-31 to 2026-03-31 | total_equity | -253,504,000 United States dollar | superseded | [clm_BE370443A771](/claim/clm_BE370443A771.md) ## 2026 - 2026-02-20 to 2026-04-30 | shares_outstanding | 232,644,477 shares | superseded | [clm_CF3D8D752E43](/claim/clm_CF3D8D752E43.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 863,934,000 United States dollar | superseded | [clm_0A25B6DBED67](/claim/clm_0A25B6DBED67.md) - 2026-03-31 to 2026-06-30 | total_assets | 4,407,937,000 United States dollar | superseded | [clm_1277660055E8](/claim/clm_1277660055E8.md) - 2026-03-31 to 2026-06-30 | total_equity | -218,117,000 United States dollar | superseded | [clm_4584DD4C30CD](/claim/clm_4584DD4C30CD.md) - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 1,020,095,000 United States dollar | superseded | [clm_62CD4092B073](/claim/clm_62CD4092B073.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | 166,837,000 United States dollar | superseded | [clm_8DBBA2F5F9E3](/claim/clm_8DBBA2F5F9E3.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 116,805,000 United States dollar | superseded | [clm_C5A298C05372](/claim/clm_C5A298C05372.md) - 2026-03-31 to 2026-06-30 | quarterly_operating_income | 236,416,000 United States dollar | superseded | [clm_D030F46391FD](/claim/clm_D030F46391FD.md) - 2026-04-30 to 2026-07-31 | shares_outstanding | 233,266,526 shares | superseded | [clm_D768CBFBB7A6](/claim/clm_D768CBFBB7A6.md) - 2026-06-30 | quarterly_research_and_development | 114,816,000 United States dollar | valid | [clm_0A67CC798380](/claim/clm_0A67CC798380.md) - 2026-06-30 | total_assets | 4,033,915,000 United States dollar | valid | [clm_17EADA40740B](/claim/clm_17EADA40740B.md) - 2026-06-30 | cash_and_equivalents | 580,580,000 United States dollar | valid | [clm_45BC85494743](/claim/clm_45BC85494743.md) - 2026-06-30 | quarterly_revenue | 853,105,000 United States dollar | valid | [clm_66BD127EA5CB](/claim/clm_66BD127EA5CB.md) - 2026-06-30 | quarterly_operating_income | 245,450,000 United States dollar | valid | [clm_72E356FF84DA](/claim/clm_72E356FF84DA.md) - 2026-06-30 | quarterly_net_income | 170,546,000 United States dollar | valid | [clm_7681142C42FD](/claim/clm_7681142C42FD.md) - 2026-06-30 | total_equity | -237,055,000 United States dollar | valid | [clm_CEEF5311B978](/claim/clm_CEEF5311B978.md) - 2026-07-31 | shares_outstanding | 229,550,985 shares | valid | [clm_CCEC5D71D8CF](/claim/clm_CCEC5D71D8CF.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.